TRPA1 and atopic eczema: Other potential novel treatments that antagonize the TRPA1 receptor include HC-030031, a TRPA1 antagonist that has been found to decrease itch in mouse models of atopic dermatitis, oxazolone and urushiol exposed mice, and LTB4-induced itch [16,17,23].